324 related articles for article (PubMed ID: 17903032)
1. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
[TBL] [Abstract][Full Text] [Related]
2. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitivity of peripheral blood lymphocytes from healthy donors and cervical cancer patients; the correspondence of in vitro data with the clinical outcome.
Gabelova A; Farkasova T; Gurska S; Machackova Z; Lukacko P; Witkovsky V
Neoplasma; 2008; 55(3):182-91. PubMed ID: 18348650
[TBL] [Abstract][Full Text] [Related]
4. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
Dunst J; Gebhart E; Neubauer S
Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
[TBL] [Abstract][Full Text] [Related]
5. Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.
Henríquez-Hernández LA; Carmona-Vigo R; Pinar B; Bordón E; Lloret M; Núñez MI; Rodríguez-Gallego C; Lara PC
Radiat Oncol; 2011 Jun; 6():60. PubMed ID: 21645372
[TBL] [Abstract][Full Text] [Related]
6. High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.
Koukourakis MI; Yannakakis D
Anticancer Res; 2001; 21(4B):2973-8. PubMed ID: 11712796
[TBL] [Abstract][Full Text] [Related]
7. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889
[TBL] [Abstract][Full Text] [Related]
8. No correlation between radiosensitivity or double-strand break repair capacity of normal fibroblasts and acute normal tissue reaction after radiotherapy of breast cancer patients.
El-Awady RA; Mahmoud M; Saleh EM; El-Baky HA; Lotayef M; Dahm-Daphi J; Dikomey E
Int J Radiat Biol; 2005 Jul; 81(7):501-8. PubMed ID: 16263653
[TBL] [Abstract][Full Text] [Related]
9. Common genomic signaling among initial DNA damage and radiation-induced apoptosis in peripheral blood lymphocytes from locally advanced breast cancer patients.
Henríquez-Hernández LA; Pinar B; Carmona-Vigo R; Bordón E; Rodríguez-Gallego C; Flores-Morales A; Lara PC
Breast; 2013 Feb; 22(1):28-33. PubMed ID: 22687815
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients.
Schnarr K; Boreham D; Sathya J; Julian J; Dayes IS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1424-30. PubMed ID: 19167839
[TBL] [Abstract][Full Text] [Related]
11. Correlation between DNA repair capacity in lymphocytes and acute side effects to skin during radiotherapy in nasopharyngeal cancer patients.
Wang WD; Chen ZT; Li DZ; Cao ZH; Sun SL; Pu P; Chen XP
Clin Cancer Res; 2005 Jul; 11(14):5140-5. PubMed ID: 16033828
[TBL] [Abstract][Full Text] [Related]
12. DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients.
Sterpone S; Cornetta T; Padua L; Mastellone V; Giammarino D; Testa A; Tirindelli D; Cozzi R; Donato V
Mutat Res; 2010 Feb; 684(1-2):43-8. PubMed ID: 19962393
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of predictive assays for acute and late radiation morbidity.
Budach W; Classen J; Belka C; Bamberg M
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():20-4. PubMed ID: 9830451
[TBL] [Abstract][Full Text] [Related]
14. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
[TBL] [Abstract][Full Text] [Related]
15. DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients.
Strasser H; Grabenbauer GG; Sprung CN; Sauer R; Distel LV
Strahlenther Onkol; 2007 Aug; 183(8):447-53. PubMed ID: 17680225
[TBL] [Abstract][Full Text] [Related]
16. Relationships between acute reactions to radiotherapy in head and neck cancer patients and parameters of radiation-induced DNA damage and repair in their lymphocytes.
Rzeszowska-Wolny J; Palyvoda O; Polanska J; Wygoda A; Hancock R
Int J Radiat Biol; 2008 Aug; 84(8):635-42. PubMed ID: 18608641
[TBL] [Abstract][Full Text] [Related]
17. Inter-relation of apoptosis and DNA double-strand breaks in patients with multiple primary cancers.
Kaminski BC; Grabenbauer GG; Sprung CN; Sauer R; Distel LV
Eur J Cancer Prev; 2006 Jun; 15(3):274-82. PubMed ID: 16679873
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.
Chistiakov DA; Voronova NV; Chistiakov PA
Acta Oncol; 2008; 47(5):809-24. PubMed ID: 18568480
[TBL] [Abstract][Full Text] [Related]
20. Moist skin care can diminish acute radiation-induced skin toxicity.
Momm F; Weissenberger C; Bartelt S; Henke M
Strahlenther Onkol; 2003 Oct; 179(10):708-12. PubMed ID: 14566480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
